INS and Alzheimer disease: Given that ε4 negative AD patients had previously shown signs of insulin resistance [62], this study suggested that cognitive effects in response to intranasal insulin may indicate disrupted insulin metabolism in AD and MCI patients that do not carry the ε4 allele.